Evidence map›Paper›PMID 37360918›Full record

ArticleCollegian (Royal College of Nursing, Australia)2023

The impact of COVID-19 on clinical research at Australian and New Zealand universities: A qualitative study.

Renu Bhutkar, Sarira El-Den, Claire L O'Reilly, Jack C Collins

Open access · hybridAbstract read
In one paragraph

Article in Collegian (Royal College of Nursing, Australia), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Renu BhutkarThe University of Sydney School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, A15, Science Rd, Camperdown, NSW 2006, Australia.
Sarira El-DenThe University of Sydney School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, A15, Science Rd, Camperdown, NSW 2006, Australia.
Claire L O'ReillyThe University of Sydney School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, A15, Science Rd, Camperdown, NSW 2006, Australia.
Jack C CollinsThe University of Sydney School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, A15, Science Rd, Camperdown, NSW 2006, Australia.
The University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The COVID-19 pandemic resulted in the implementation of social distancing measures, travel restrictions, and infection control measures that introduced a myriad of disruptions in the conduct of clinical research worldwide. As a result, many aspects of clinical research were variably impacted. Aim: To explore the impact of the first 18 months of the COVID-19 pandemic on clinical research across accredited nursing, pharmacy, and medicine program providers in Australian and New Zealand universities. Methods: Representatives from all program providers across Australian and New Zealand universities, with publicly available contact information, were invited to participate in this qualitative study, whereby semi-structured interviews were completed with participants who held senior research or leadership positions within their institution. Interviews were transcribed verbatim and inductively analysed using thematic content analysis. Findings: Interviews were conducted with 16 participants between August and October 2021. Two major themes were identified ( Discussion: The impact on clinical research in Australian and New Zealand universities included changes to data collection methods, a perceived decreased quality of research, changes to collaboration, neglect of basic disease research, and loss of the research workforce. Conclusion: This study highlights the impact of the COVID-19 pandemic on clinical research within the Australian and New Zealand university context. Implications of these impacts should be considered to ensure long-term sustainability of research and preparedness for future disruptions.

Indexed as

AustraliaClinical researchCOVID-19New ZealandPandemicUniversities

Identifiers

PMID37360918
PMCPMC10165013
OpenAlexW4381591318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.